Real-World Data Reveals High Discontinuation and Frequent Reinitiation Rates Among GLP-1 Users with Type 2 Diabetes
The landscape of metabolic medicine is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists and dual agonists redefine…
